BioSight
Companies
Aclaris Therapeutics, Inc. logo

ACRS

NASDAQWAYNE, PA
Aclaris Therapeutics, Inc.

Aclaris Therapeutics develops product candidates across multiple therapeutic areas, though the specific therapeutic focus and modalities are not detailed in this excerpt. Aclaris is in the clinical development stage, with planned trials and regulatory filings for its product candidates ahead. The company relies on third-party manufacturing and partnerships for development and commercialization, and will need additional financing to fund operations.

Price history not yet available for ACRS.

Pipeline

No pipeline data on record yet.

Catalyst Calendar

No catalyst events on record for yet. Check back after the next daily ingest.

Disclaimer·BioSight aggregates publicly available data (SEC EDGAR, ClinicalTrials.gov, FDA, company press releases) and is provided as is for informational purposes only. Nothing here is investment, financial, legal, tax, or medical advice, or an offer to buy or sell any security. We make no warranty as to accuracy, completeness, or timeliness; dates and filings may contain errors or be superseded without notice; past events do not predict future outcomes. To the maximum extent permitted by law, BioSight, its operators, contributors, and affiliates disclaim all liability for any loss or damage arising from use of or reliance on this site. You are solely responsible for your own investment decisions — consult a licensed professional before acting on any information.

Unlock 12-month calendar